SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 57.05-0.6%Dec 9 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (454)12/16/1999 2:44:00 PM
From: Biomaven   of 52153
 
Mike,

The tracking stock issue is complex. Some people won't touch them, but I'm content to hold GZMO. My take is that even though legal title to the assets (particularly from a creditor's viewpoint)is held by the parent, GZMO shareholders will still sink or swim based on the results of GZMO itself.

Here's the explanation of the CEGE deal from a GZMO release:

In exchange for these assets and the $60.0 million in cash, Genzyme Molecular Oncology will reserve approximately 12.5 million GZMO designated shares for the benefit of Genzyme General.

Genzyme General intends to explore the potential to either sell the GZMO designated shares reserved for its benefit to financial or strategic investors with an interest in Genzyme Molecular Oncology or sell the GZMO designated shares in a registered public offering in 2000. If the GZMO designated shares are not otherwise sold for the benefit of Genzyme General, they will be distributed as a dividend to holders of GENZ stock.

Hopefully they will be sold in an offering rather than distributed - we've seen that GENZ shareholders basically dump whatever's given to them.

GZMO basically got a sweet deal here - $60m in cash plus the CEGE oncology assets for around $60m in GZMO stock at current values.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News